FDA Clearance Tracker · P100047-S101
HeartWare HVAD System
Last checked: Nov 20, 2026Latest source record: Dec 15, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 15, 2017
Approved
Time to decision
178 days
Received Jun 20, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the addition of cleaning specifications and ongoing controls and monitoring requirements to verify compliance to the new cleanliness specifications.
Source documents
Other decisions for Medtronic
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262716 · Decided Nov 6, 2026 · 98 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.